The eye cancer field has really heated up in the past few years, which has added to everyone's stress over publications and grants, but has also elevated a once second-tier cancer to the limelights. Of course, the old guard are still working desparately to stay relevant, but many are resistant to the changing face of scientific research. Here's an example of an article that is clearly trying to move ahead, but has missed that most important leap:
Barak V, Frenkel S, Kalickman I, Maniotis AJ, Folberg R, Peer J. (2007) "Serum markers to detect metastatic uveal melanoma." Anticancer Research 27(4A):1897-900.
Here's the European competition along the same lines, but modernified:
Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Scheibenbogen C, Thiel E, Foerster MH, Keilholz U. (2007) "Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma." Clinical Cancer Research 13(4):1171-8.
Can you spot the major differences?
Thursday, July 26, 2007
Thursday, July 12, 2007
Ned over at StarChamber turned me on to a new option on Google Maps: you can now include waypoints in your driving directions. Being a consummate wonk, I went to work using this feature for entirely the wrong reasons, and found that, although smaller in area, Central Park in New York has a greater perimeter than Forest Park in St. Louis. As if Google hasn't already wasted enough of my time...
Monday, July 09, 2007
Just when I thought I had some semblance of a grasp on the current state of the onlines.
http://www.encyclopediadramatica.com/index.php/DO_NOT_WANT
This has all that I have learnt over the past month, including:
Encyclopedia Dramatica
LOLcats
4chan
/b/tards
and, ultimately, the passing on of webmemes like AYBABTU to the next generation.
http://www.encyclopediadramatica.com/index.php/DO_NOT_WANT
This has all that I have learnt over the past month, including:
Encyclopedia Dramatica
LOLcats
4chan
/b/tards
and, ultimately, the passing on of webmemes like AYBABTU to the next generation.
Subscribe to:
Posts (Atom)